https://www.selleckchem.com/products/dooku1.html
Patients with obstructive sleep apnea symptoms (p=0.026) and grade of adenoid (p=0.04 showed a significant relationship with surgery booking after one year. The probability of booking for surgery for those who used Maxitrol® was 1.394 times higher than for those who were not using it (odds ratio [OR]=1.394; 95% confidence interval [CI]=0.549-3.537). Suppression of growth and eye complications were not reported in any of our patients. Conclusion In this small sample, the use of Maxitrol® in the pediatric age group below two years with a
Like
Comment
Share
